胎牛血清的全球市场(2022年～2030年)

全球胎牛血清的市场规模在2022年到2030年间预计将以8.58％的年复合成长率增长，达到8亿美元以上。

本报告提供全球胎牛血清市场相关调查分析，提供市场分析，市场参与企业等系统性资讯。

目录

第1章 报告的简介

• 报告的说明
  • 调查手法
  • 报告的目的
  • 资料来源
• 缩写/简称
• 假设
• 限制事项

第2章 摘要整理

第3章 胎牛血清市场:终端用户各类型

• 研究机关及学术机构
• 产业(製药，生物科技，其他)

第4章 胎牛血清市场:各用途

• 药物研发
• 细胞培养培养基
• 体外受精
• 人及动物的疫苗生产
• 诊断
• 其他

第5章 全球胎牛血清市场:各地区

• 北美
  • 美国
  • 加拿大
• 南美
  • 巴西
  • 墨西哥
  • 其他的南美
• 欧洲
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 义大利
  • 其他的西欧
• 亚太地区
  • 日本
  • 印度
  • 中国
  • 澳洲
  • 其他的亚太地区
• 中东和非洲
  • GCC各国
  • 南非
  • 以色列
  • 其他的中东
• 全球其他地区

第6章 主要市场参与企业

• Merck Group(德国)
• Thermo Fisher Scientific, Inc.(美国)
• GE Healthcare(英国)
• TCS Biosciences Ltd(英国)
• Hi Media Laboratories(印度)
• Atlanta Biologicals, Inc.(美国)
• PAN-Biotech(英国)
• Rocky Mountain Biologicals(美国)
• Bovogen Biologicals Pty Ltd(澳洲)
• Tissue Culture Biologicals(美国)
• 其他

第7章 附录

• 免责声明
• Sprout 关于Intelligence

REPORT OBJECTIVES

The report "Fetal Bovine Serum: Global Market Intelligence (2022-2030)" provides market intelligence on the different market segments, based on End-user type, Application and geography. Market size and forecast (2022-2030) has been provided in the report. The primary objectives of this report are to provide 1) comprehensive global market intelligence through detailed segmentation, 2) market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends, 3) detailed analysis of current dynamics and trends, key market players, and strategies in the market, 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants, 5) provide emerging opportunities in the market and the future impact of major drivers and restraints of the market and, 6) support decision makers in making cost-effective business decisions.

RESEARCH METHODOLOGY

In our market size and forecast determination efforts, an extensive secondary research was initially completed to gain a good perspective of the market in each region. Extensive primary research was also carried out by interviewing the key executives from the industry. These interviews helped us to fill-in the data gaps after secondary research. Several secondary sources such as encyclopedia, directories, and databases have been used to identify and collect information useful for this extensive techno-commercial study. The respondents - selected experts from manufacturers and selected suppliers - have been interviewed to obtain and verify critical information as well as to assess the future prospects. The usage of obtained information is based on the perceived reliability by the research team. In many cases, a combination of several sources was used. Sprout Intelligence provides an in-depth analysis of the market segmentation, which is a critical element of the market intelligence reports at Sprout Intelligence.

KEY AUDIENCE

Executives in marketing, strategic planning and new End-user type development will find such discussions in our reports pertinent and useful. Management consultants, investment bankers, manufacturers, distributors, suppliers, and regulatory authorities are amongst our regular clientele served.

DATA SOURCES

The general data sources used in this report are company websites, trade association publications, regulatory authorities, journals, magazines, news websites, press releases, media publications, interaction with industry experts, company executives, research papers, articles, patents, scientific literature, among many others.

KEY FINDINGS FROM THE REPORT

Fetal Bovine Serum market is expected to grow at 8.58% CAGR from 2022 to 2030.

Due to having a very low level of antibodies and containing more growth factors, allowing for versatility in many different cell culture applications, Fetal bovine serum used serum-supplement for the in vitro cell culture of eukaryotic cells.

USA, United Kingdom and Germany are the leading countries in fetal bovine serum market.

Merck Group, Thermo Fisher Scientific Inc., GE Healthcare, TCS Biosciences Ltd, Hi Media Laboratories, Atlanta Biologicals, Inc., are leading manufacturers of Fetal bovine serum.

Sprout Intelligence expert team estimated that the global Fetal bovine serum market was worth more than USD 800 million.

Table of Contents

1. Report Introduction

• 1.1. Report Description
  • 1.1.1. Research Methodology
  • 1.1.2. Report Objectives
  • 1.1.3. Data Sources
• 1.2. Acronyms / Abbreviations
• 1.3. Assumptions
• 1.4. Limitations

2. Executive Summary

3. Fetal Bovine Serum Market, By End-user type

• 3.1. Research & academic institutes
• 3.2. Industry (Pharma, biotech, etc.,)

4. Fetal Bovine Serum Market, By Application

• 4.1. Drug discovery
• 4.2. Cell culture media
• 4.3. In vitro fertilization
• 4.4. Human and animal vaccine production
• 4.5. Diagnostics
• 4.6. Others

5. Global Fetal Bovine Serum Market, By Region

• 5.1. North America (NA)
  • 5.1.1. USA
  • 5.1.2. Canada
• 5.2. Latin America
  • 5.2.1. Brazil
  • 5.2.2. Mexico
  • 5.2.3. Rest of Latin America
• 5.3. Europe (EU)
  • 5.3.1. U.K
  • 5.3.2. Germany
  • 5.3.3. France
  • 5.3.4. Spain
  • 5.3.5. Italy
  • 5.3.6. Rest of Western Europe
• 5.4. Asia-Pacific (APAC)
  • 5.4.1. Japan
  • 5.4.2. India
  • 5.4.3. China
  • 5.4.4. Australia
  • 5.4.5. Rest of Asia-Pacific
• 5.5. Middle East & Africa
  • 5.5.1. GCC Countries
  • 5.5.2. South Africa
  • 5.5.3. Israel
  • 5.5.4. Rest of Middle East & Africa
• 5.6. Rest of World

6. Key Market Players

• 6.1. Merck Group, Germany
• 6.2. Thermo Fisher Scientific, Inc., United States
• 6.3. GE Healthcare, United Kingdom
• 6.4. TCS Biosciences Ltd, United Kingdom
• 6.5. Hi Media Laboratories, India
• 6.6. Atlanta Biologicals, Inc., United states
• 6.7. PAN-Biotech, United Kingdom
• 6.8. Rocky Mountain Biologicals, United states
• 6.9. Bovogen Biologicals Pty Ltd, Australia
• 6.10. Tissue Culture Biologicals, United states
• 6.11. Others.

7. Appendix

• 7.1. Disclaimer
• 7.2. About Sprout Intelligence